Cardiotoxicity of imatinib: At the heart of the problem

Leuk Res. 2011 Jan;35(1):36-7. doi: 10.1016/j.leukres.2010.09.021.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Heart / drug effects*
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Piperazines / adverse effects*
  • Piperazines / therapeutic use
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate